Skip to main content
AAPL+0.69%MSFT+0.96%GOOGL+1.78%NVDA+3.63%AMZN+1.69%SPCX+1.42%TSM+2.92%AVGO+2.47%META+1.21%TSLA+1.46%LLY+0.01%WMT+0.08%JPM-0.04%BRK-B+0.02%V+0.01%SKHY0.00%AMD+3.30%MU+2.48%XOM0.00%JNJ+0.15%MA+0.07%ABBV+0.08%ASMLa-9.33%COST+0.19%1398.HK+0.25%KO+0.03%CVX+0.03%0700.HK-1.26%PG+0.09%CSCO+0.07%0939.HK0.00%1816.HK+3.45%HD+0.06%3988.HK-1.13%BAC+0.05%GE0.00%0857.HK-0.49%ORCL-0.01%UNH+0.02%1288.HK-0.45%PM+0.02%0005.HK-3.08%NVS-0.01%HSBA.L-3.62%INTC+3.30%AZN-0.01%MS+0.02%RTX+0.14%ORp-0.36%TMO+0.14%GBPTRY+0.41%GBPHKD+0.32%GBPMXN-0.28%USDILS+0.16%USDCOP-0.04%GBPSGD0.00%PLNJPY0.00%GBPZAR0.00%USDZAR0.00%USDPLN0.00%EURNZD0.00%AUDCHF0.00%EURSEK0.00%GBPUSD0.00%GBPCHF0.00%USDDKK0.00%USDHKD0.00%CADJPY0.00%GBPCAD0.00%NZDCAD0.00%GBPNZD0.00%GBPAUD0.00%EURCAD0.00%EURJPY0.00%EURNOK0.00%EURUSD0.00%CADCHF0.00%NZDCHF0.00%NZDSGD0.00%EURCZK0.00%NOKJPY0.00%AUDCAD0.00%CHFSGD0.00%SGDJPY0.00%AUDSGD0.00%NZDUSD0.00%GBPJPY0.00%EURGBP0.00%AUDNZD0.00%AUDJPY0.00%AUDUSD0.00%USDJPY0.00%USDCNH0.00%EURCHF0.00%USDMXN0.00%USDNOK0.00%USDTHB0.00%USDTRY0.00%USDSEK0.00%USDCAD0.00%USDCHF0.00%EURHKD0.00%EURAUD0.00%AUDNOK0.00%EURCNH0.00%EURZAR0.00%EURSGD0.00%AUDDKK0.00%CHFSEK0.00%USDSGD0.00%CHFJPY0.00%NZDJPY0.00%CHFNOK0.00%EURDKK0.00%EURPLN0.00%NZDMXN0.00%GAGUSD0.00%W10.00%XAGUSD0.00%HG10.00%S10.00%C10.00%XNGUSD0.00%USOIL0.00%XAUUSD0.00%SUGAR0.00%COTTON0.00%COFFEE0.00%BTCUSD+2.59%ETHUSD+77.41%USDTUSD+0.09%XRPUSD+64.83%SOLUSD+72.04%TRXUSDT+1.25%ZECUSDT+4.46%XMRUSDT+7.09%DOGEUSD+72.43%LINKUSD+1.03%XLMUSD+1.76%BCHUSDT+2.47%LTCUSD+64.72%UNIUSD+5.25%TONUSD+74.91%SUIUSD-0.68%HBARUSDT+0.39%TAOUSDT+2.40%AAVEUSD-0.71%ONDOUSDT-0.62%DOTUSDT-1.60%ICPUSDT-5.80%WLDUSDT-0.52%ARBUSDT-0.96%ATOMUSDT-3.84%INJUSDT-4.57%STXUSDT+2.91%PYTHUSDT+0.33%TIAUSDT-1.31%FETUSDT-3.07%SEIUSDT-1.94%JUPUSDT-4.27%GRTUSDT+0.60%OPUSDT+0.63%IOTAUSDT-1.77%POLUSDT-0.09%WIFUSDT-2.78%AXSUSDT+0.59%EOSUSDT+0.85%IMXUSDT-3.33%FARTCOINUSDT-0.20%GALAUSDT-2.18%DYDXUSDT-3.52%ORDIUSDT-0.27%NOTUSDT-1.52%RONINUSDT+0.62%AAPL+0.69%MSFT+0.96%GOOGL+1.78%NVDA+3.63%AMZN+1.69%SPCX+1.42%TSM+2.92%AVGO+2.47%META+1.21%TSLA+1.46%LLY+0.01%WMT+0.08%JPM-0.04%BRK-B+0.02%V+0.01%SKHY0.00%AMD+3.30%MU+2.48%XOM0.00%JNJ+0.15%MA+0.07%ABBV+0.08%ASMLa-9.33%COST+0.19%1398.HK+0.25%KO+0.03%CVX+0.03%0700.HK-1.26%PG+0.09%CSCO+0.07%0939.HK0.00%1816.HK+3.45%HD+0.06%3988.HK-1.13%BAC+0.05%GE0.00%0857.HK-0.49%ORCL-0.01%UNH+0.02%1288.HK-0.45%PM+0.02%0005.HK-3.08%NVS-0.01%HSBA.L-3.62%INTC+3.30%AZN-0.01%MS+0.02%RTX+0.14%ORp-0.36%TMO+0.14%GBPTRY+0.41%GBPHKD+0.32%GBPMXN-0.28%USDILS+0.16%USDCOP-0.04%GBPSGD0.00%PLNJPY0.00%GBPZAR0.00%USDZAR0.00%USDPLN0.00%EURNZD0.00%AUDCHF0.00%EURSEK0.00%GBPUSD0.00%GBPCHF0.00%USDDKK0.00%USDHKD0.00%CADJPY0.00%GBPCAD0.00%NZDCAD0.00%GBPNZD0.00%GBPAUD0.00%EURCAD0.00%EURJPY0.00%EURNOK0.00%EURUSD0.00%CADCHF0.00%NZDCHF0.00%NZDSGD0.00%EURCZK0.00%NOKJPY0.00%AUDCAD0.00%CHFSGD0.00%SGDJPY0.00%AUDSGD0.00%NZDUSD0.00%GBPJPY0.00%EURGBP0.00%AUDNZD0.00%AUDJPY0.00%AUDUSD0.00%USDJPY0.00%USDCNH0.00%EURCHF0.00%USDMXN0.00%USDNOK0.00%USDTHB0.00%USDTRY0.00%USDSEK0.00%USDCAD0.00%USDCHF0.00%EURHKD0.00%EURAUD0.00%AUDNOK0.00%EURCNH0.00%EURZAR0.00%EURSGD0.00%AUDDKK0.00%CHFSEK0.00%USDSGD0.00%CHFJPY0.00%NZDJPY0.00%CHFNOK0.00%EURDKK0.00%EURPLN0.00%NZDMXN0.00%GAGUSD0.00%W10.00%XAGUSD0.00%HG10.00%S10.00%C10.00%XNGUSD0.00%USOIL0.00%XAUUSD0.00%SUGAR0.00%COTTON0.00%COFFEE0.00%BTCUSD+2.59%ETHUSD+77.41%USDTUSD+0.09%XRPUSD+64.83%SOLUSD+72.04%TRXUSDT+1.25%ZECUSDT+4.46%XMRUSDT+7.09%DOGEUSD+72.43%LINKUSD+1.03%XLMUSD+1.76%BCHUSDT+2.47%LTCUSD+64.72%UNIUSD+5.25%TONUSD+74.91%SUIUSD-0.68%HBARUSDT+0.39%TAOUSDT+2.40%AAVEUSD-0.71%ONDOUSDT-0.62%DOTUSDT-1.60%ICPUSDT-5.80%WLDUSDT-0.52%ARBUSDT-0.96%ATOMUSDT-3.84%INJUSDT-4.57%STXUSDT+2.91%PYTHUSDT+0.33%TIAUSDT-1.31%FETUSDT-3.07%SEIUSDT-1.94%JUPUSDT-4.27%GRTUSDT+0.60%OPUSDT+0.63%IOTAUSDT-1.77%POLUSDT-0.09%WIFUSDT-2.78%AXSUSDT+0.59%EOSUSDT+0.85%IMXUSDT-3.33%FARTCOINUSDT-0.20%GALAUSDT-2.18%DYDXUSDT-3.52%ORDIUSDT-0.27%NOTUSDT-1.52%RONINUSDT+0.62%

Thermo Fisher launches AmpSure qPCR mixes

NEWS

November 5, 2026 at 14:04 UTC

3 min read
Unbranded qPCR instrument and reagents in a genetics lab illustrating new AmpSure qPCR mixes launch TMO

Key Points

  • 01Thermo Fisher (TMO) introduced AmpSure Universal SYBR Green and Probe qPCR Master Mixes on November 5, 2026
  • 02New AmpSure mixes are value-priced for everyday quantitative PCR applications
  • 03Products are designed for reliable, reproducible performance across a broad range of instruments
  • 04SYBR Green supports gene expression; Probe supports multiplexing, genotyping and microbe detection.

Thermo Fisher unveils value-priced AmpSure qPCR mixes

Thermo Fisher Scientific (TMO) has introduced the Thermo Scientific AmpSure Universal SYBR Green and Probe qPCR Master Mixes, expanding its portfolio of quantitative PCR reagents. Announced on November 5, 2026, the new products are positioned as value-priced master mixes designed to deliver consistent performance for everyday qPCR applications while helping laboratories manage reagent costs.

The AmpSure family consists of two master mixes, allowing researchers to select the detection chemistry that best fits their experiments. Both mixes are intended to support reliable and reproducible quantitative PCR performance, enabling users to generate quality data, complete experiments and advance research projects efficiently.

Product design and key applications

AmpSure SYBR Green master mix is aimed at routine gene expression analysis, offering a straightforward option for standard qPCR workflows. AmpSure Probe master mix supports multiplexing and a broader range of applications, including gene expression analysis, genotyping and microbe detection, giving users flexibility for more complex assay designs.

The two chemistries are offered at the same price per reaction, so laboratories can choose between SYBR Green and Probe detection based on experimental needs rather than cost differences. This structure is intended to keep reagent spending predictable while preserving the ability to match the chemistry to specific assay requirements.

Compatibility with existing lab workflows

Both AmpSure Universal SYBR Green and Probe mixes are designed for broad compatibility with leading qPCR instruments. They also work with a wide range of reverse transcriptases, primers and probes, allowing researchers to integrate the reagents into their existing setups without significant changes to hardware or assay components.

This compatibility extends across instruments, assays and workflows that laboratories already use, reducing the need to modify protocols when adopting the new reagents. By fitting into established systems, the mixes aim to help academic, government and small biotech researchers maintain continuity in their operations.

Balancing performance and budget needs

Thermo Fisher describes consistent performance as essential for generating quality data, completing experiments and publishing research, and positions AmpSure mixes to meet these requirements at a value-focused price point. The products are targeted at researchers who need dependable qPCR reagents that support routine use without straining budgets.

By combining reliable performance, broad compatibility and equal pricing across SYBR Green and Probe formats, the AmpSure Universal qPCR Master Mixes are intended to help laboratories make the most of their research budgets. The launch adds an affordable option to the qPCR reagent market for users seeking both quality and cost control.

Key Takeaways

  • 01Thermo Fisher (TMO) has expanded its qPCR portfolio with a dual-chemistry AmpSure line that focuses on everyday research needs.
  • 02Equal per-reaction pricing for SYBR Green and Probe chemistries allows labs to choose assays based on science rather than cost.
  • 03Broad compatibility with existing instruments and reagents reduces barriers to adoption and supports continuity in lab workflows.

Thermo Fisher launches AmpSure qPCR mixes | Trading Dashboard